Patents Represented by Attorney, Agent or Law Firm Angela M. Stone
  • Patent number: 7528264
    Abstract: Hydride process for making acyclic diol intermediates from cyclic intermediates, useful in antibacterial quinolone synthesis.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: May 5, 2009
    Assignee: The Procter & Gamble Company
    Inventors: Michael Patrick Hayes, Tammy Talbot Schunk
  • Patent number: 7462597
    Abstract: Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
    Type: Grant
    Filed: May 4, 2005
    Date of Patent: December 9, 2008
    Assignee: The Procter & Gamble Company
    Inventors: Robert Joseph Isfort, Wieslaw Adam Mazur
  • Patent number: 7456279
    Abstract: Process for making 7-cycloamino-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acids. Borate ester compounds suitable for use in such process.
    Type: Grant
    Filed: March 26, 2007
    Date of Patent: November 25, 2008
    Assignee: The Procter & Gamble Company
    Inventor: Michael Reilly
  • Patent number: 6190644
    Abstract: Disclosed are oral compositions comprising one or more linear polyphosphates having an average chain length of about 4 or more, sodium monofluorophosphate, a buffering agent, an abrasive polishing material containing less than 23% calcium, and one or more aqueous carriers, wherein the oral composition has a total water content of from about 5% to about 20%.
    Type: Grant
    Filed: November 21, 1996
    Date of Patent: February 20, 2001
    Assignee: The Procter & Gamble Company
    Inventors: Stephen Francis McClanahan, Donald James White, Jr., Edward Russell Cox
  • Patent number: 6187295
    Abstract: Disclosed are methods for reducing the astringency of dentifrice composition containing stannous comprising administering to the subject a dentifrice composition comprising stannous. The dentifrice composition comprises stannous ions, poloxamer, and aqueous carriers. The efficacy of this dentifrice composition containing stannous will not be reduced by the poloxamer. The dentifrice composition may also contain a polyphosphate as long as the water content is limited and the stannous ion is not provided from stannous fluoride. The polyphosphate will also not reduce the efficacy of the stannous. Alternatively, the dentifrice composition may be a dual phase composition. The first dentifrice composition will contain a polyphosphate having an average chain length of about 4 or more and have a limited water content while the second dentifrice composition will contain stannous ions. In the dual phase composition, the poloxamer will be present in the first or second dentifrice compositions or both compositions.
    Type: Grant
    Filed: November 30, 1998
    Date of Patent: February 13, 2001
    Assignee: The Procter & Gamble Company
    Inventor: William Michael Glandorf
  • Patent number: 5733530
    Abstract: Disclosed are tartar control dentifrice compositions containing certain ranges of thymol. These compositions can also include propylene glycol and/or one or more antibacterial agents.
    Type: Grant
    Filed: August 30, 1996
    Date of Patent: March 31, 1998
    Assignee: The Procter & Gamble Company
    Inventors: Lori Ann Bacca, Anthony Charles Lanzalaco
  • Patent number: D657703
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: April 17, 2012
    Assignees: The Procter & Gamble Company, ColoRight Ltd.
    Inventors: Wolfgang Stegmann, Phong Duy Vu, Sven Wuttig